Comparing the Efficacy and Safety of Finerenone and Spironolactone in the Treatment of Primary Aldosteronism
Conditions: Primary Aldosteronism; Hypertension Interventions: Drug: Finerenone; Drug: Spironolactone Sponsors: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School; National Key Research and Development Program of China; National Natural Science Foundation of China Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials